Literature DB >> 26358929

Assessing non-specific symptoms in epidemiological studies: Development and validation of the Symptoms and Perceptions (SaP) questionnaire.

Joris Yzermans1, Christos Baliatsas2, Sandra van Dulmen3, Irene Van Kamp4.   

Abstract

OBJECTIVES: To describe the development of the Symptoms and Perceptions (SaP) questionnaire, a new instrument measuring diversity and severity features and related perceptions of non-specific (physical and psychological) symptoms (NSS) and to test its reliability and validity within an epidemiological setting.
METHODS: First, a Delphi study was performed to develop the items of the questionnaire. Its psychometric properties were then tested within the context of an epidemiological study. This study yielded questionnaire data and general practice registry data from a sample of 5933 Dutch adults. Principal component analyses (PCA) were performed to test the factorial structure of the symptom assessment subscales of the SaP. Indicators of reliability and convergent validity were examined separately for the questionnaire parts of symptoms and perceptions. Criterion validity of the symptom scores of the SaP was also explored.
RESULTS: The factorial structure of the symptom subscales reflected meaningful sets of clusters, indicative of the representation of all relevant organ systems. The SaP showed high reliability and good convergent validity for both the symptoms and perceptions part. It was also able to identify, to a certain degree, cases of diagnosed somatoform disorders and multiple NSS in primary care. Additionally, the scores on the "psychological" factor fairly predicted the diagnosis of common mental disorders.
CONCLUSIONS: The SaP questionnaire is a reliable and valid self-reported measure of diverse features of NSS and corresponding perceptions. It can also be a useful tool for the identification of multiple somatic symptoms and related disorders in general practice and assessment of psychological problems in epidemiological studies. Further validation of the questionnaire in different samples and settings will establish the promising psychometric properties demonstrated in the present study.
Copyright © 2015 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  Epidemiological studies; Medically unexplained symptoms; Non-specific symptoms; Questionnaires; Reliability; Validity

Mesh:

Year:  2015        PMID: 26358929     DOI: 10.1016/j.ijheh.2015.08.006

Source DB:  PubMed          Journal:  Int J Hyg Environ Health        ISSN: 1438-4639            Impact factor:   5.840


  4 in total

1.  A cross-sectional study of the association between mobile phone use and symptoms of ill health.

Authors:  Yong Min Cho; Hee Jin Lim; Hoon Jang; Kyunghee Kim; Jae Wook Choi; Chol Shin; Seung Ku Lee; Jong Hwa Kwon; Nam Kim
Journal:  Environ Health Toxicol       Date:  2016-10-26

2.  The impact of health symptoms on health-related quality of life in early-stage breast cancer survivors.

Authors:  K M de Ligt; M Heins; J Verloop; N P M Ezendam; C H Smorenburg; J C Korevaar; S Siesling
Journal:  Breast Cancer Res Treat       Date:  2019-09-11       Impact factor: 4.872

3.  Applying machine learning on health record data from general practitioners to predict suicidality.

Authors:  Kasper van Mens; Elke Elzinga; Mark Nielen; Joran Lokkerbol; Rune Poortvliet; Gé Donker; Marianne Heins; Joke Korevaar; Michel Dückers; Claire Aussems; Marco Helbich; Bea Tiemens; Renske Gilissen; Aartjan Beekman; Derek de Beurs
Journal:  Internet Interv       Date:  2020-08-27

4.  Protocol of the Healthy Brain Study: An accessible resource for understanding the human brain and how it dynamically and individually operates in its bio-social context.

Authors:  Esther Aarts; Agnes Akkerman; Mareike Altgassen; Ronald Bartels; Becky Beckers; Kirsten Bevelander; Erik Bijleveld; Esmeralda Blaney Davidson; Annemarie Boleij; Janita Bralten; Toon Cillessen; Jurgen Claassen; Roshan Cools; Ineke Cornelissen; Martin Dresler; Thijs Eijsvogels; Myrthe Faber; Guillén Fernández; Bernd Figner; Matthias Fritsche; Sascha Füllbrunn; Surya Gayet; Marleen M. H. J. van Gelder; Marcel van Gerven; Sabine Geurts; Corina U. Greven; Martine Groefsema; Koen Haak; Peter Hagoort; Yvonne Hartman; Beatrice van der Heijden; Erno Hermans; Vivian Heuvelmans; Florian Hintz; Janet den Hollander; Anneloes M. Hulsman; Sebastian Idesis; Martin Jaeger; Esther Janse; Joost Janzing; Roy P. C. Kessels; Johan C. Karremans; Willemien de Kleijn; Marieke Klein; Floris Klumpers; Nils Kohn; Hubert Korzilius; Bas Krahmer; Floris de Lange; Judith van Leeuwen; Huaiyu Liu; Maartje Luijten; Peggy Manders; Katerina Manevska; José P. Marques; Jon Matthews; James M. McQueen; Pieter Medendorp; René Melis; Antje Meyer; Joukje Oosterman; Lucy Overbeek; Marius Peelen; Jean Popma; Geert Postma; Karin Roelofs; Yvonne G. T. van Rossenberg; Gabi Schaap; Paul Scheepers; Luc Selen; Marianne Starren; Dorine W. Swinkels; Indira Tendolkar; Dick Thijssen; Hans Timmerman; Rayyan Tutunji; Anil Tuladhar; Harm Veling; Maaike Verhagen; Jasper Verkroost; Jacqueline Vink; Vivian Vriezekolk; Janna Vrijsen; Jana Vyrastekova; Selina van der Wal; Roel Willems; Arthur Willemsen
Journal:  PLoS One       Date:  2021-12-29       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.